JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Murphy Oil
MUR
$5.12B
| $13.5M | ﹤0.01% |
323,893
-190,946
| -37% | -$8.69M |
|
1627
Quest Diagnostics
DGX
$26.2B
| $13.4M | ﹤0.01% |
185,226
-129,542
| -41% | -$9.56M |
|
|
CBL
1628
DELISTED
CBL& Associates Properties, Inc.
CBL
| $13.4M | ﹤0.01% |
827,029
-487,029
| -37% | -$8.78M |
|
|
PXD
1629
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $13.4M | ﹤0.01% |
+96,562
| New | +$15.3M |
|
|
SJR
1630
DELISTED
Shaw Communications Inc.
SJR
| $13.4M | ﹤0.01% |
614,525
+54,147
| +10% | +$1.21M |
|
1631
Stoneridge
SRI
$193M
| $13.4M | ﹤0.01% |
1,141,383
-40,631
| -3% | -$491K |
|
|
BNFT
1632
DELISTED
Benefitfocus, Inc.
BNFT
| $13.3M | ﹤0.01% |
303,945
+9,309
| +3% | +$351K |
|
1633
Webster Financial
WBS
$12.8B
| $13.3M | ﹤0.01% |
336,931
+5,847
| +2% | +$221K |
|
|
TGI
1634
DELISTED
Triumph Group
TGI
| $13.3M | ﹤0.01% |
201,904
-188,656
| -48% | -$12.2M |
|
|
UNVR
1635
DELISTED
Univar Solutions Inc.
UNVR
| $13.3M | ﹤0.01% |
+511,516
| New | +$13.5M |
|
1636
CarMax
KMX
$8.26B
| $13.3M | ﹤0.01% |
201,056
-58,591
| -23% | -$4.18M |
|
|
AVP
1637
DELISTED
Avon Products, Inc.
AVP
| $13.3M | ﹤0.01% |
2,124,625
-2,747,535
| -56% | -$20.4M |
|
|
SVU
1638
DELISTED
SUPERVALU Inc.
SVU
| $13.3M | ﹤0.01% |
234,834
+30,361
| +15% | +$2.02M |
|
1639
Rio Tinto
RIO
$164B
| $13.3M | ﹤0.01% |
322,329
-509,381
| -61% | -$22.4M |
|
1640
Neurocrine Biosciences
NBIX
$16.5B
| $13.3M | ﹤0.01% |
277,796
+79,823
| +40% | +$3.38M |
|
|
HMHC
1641
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $13.2M | ﹤0.01% |
524,965
+337,350
| +180% | +$8.37M |
|
1642
iShares US Home Construction ETF
ITB
$2.4B
| $13.2M | ﹤0.01% |
481,344
+5,216
| +1% | +$142K |
|
1643
Korn Ferry
KFY
$4.25B
| $13.2M | ﹤0.01% |
379,101
-21,944
| -5% | -$725K |
|
1644
CALL
EOG Resources
EOG
$75.2B
| $13.2M | ﹤0.01% |
150,500
-30,500
| -17% | -$2.82M |
|
1645
NVR
NVR
$17.1B
| $13.2M | ﹤0.01% |
9,828
-10,308
| -51% | -$13.9M |
|
|
TWTR
1646
CALL
DELISTED
Twitter, Inc.
TWTR
| $13.1M | ﹤0.01% |
363,010
-75,871
| -17% | -$3.1M |
|
|
GOV
1647
DELISTED
Government Properties Income Trust
GOV
| $13.1M | ﹤0.01% |
708,322
+11,600
| +2% | +$237K |
|
1648
ICU Medical
ICUI
$4.55B
| $13.1M | ﹤0.01% |
137,199
+14,008
| +11% | +$1.31M |
|
1649
Steris
STE
$23.2B
| $13.1M | ﹤0.01% |
203,265
+93,732
| +86% | +$6.32M |
|
|
XCRA
1650
DELISTED
Xcerra Corporation
XCRA
| $13.1M | ﹤0.01% |
1,728,864
+899,300
| +108% | +$8.07M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.